1789 related articles for article (PubMed ID: 10852536)
1. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Lucchinetti C; Brück W; Parisi J; Scheithauer B; Rodriguez M; Lassmann H
Ann Neurol; 2000 Jun; 47(6):707-17. PubMed ID: 10852536
[TBL] [Abstract][Full Text] [Related]
2. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
3. Neuropathology of multiple sclerosis-new concepts.
Kornek B; Lassmann H
Brain Res Bull; 2003 Aug; 61(3):321-6. PubMed ID: 12909302
[TBL] [Abstract][Full Text] [Related]
4. Neuropathology in multiple sclerosis: new concepts.
Lassmann H
Mult Scler; 1998 Jun; 4(3):93-8. PubMed ID: 9762654
[TBL] [Abstract][Full Text] [Related]
5. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected].
Komoly S
Ideggyogy Sz; 2005 Jan; 58(1-2):40-3. PubMed ID: 15884397
[TBL] [Abstract][Full Text] [Related]
6. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.
Lucchinetti CF; Mandler RN; McGavern D; Bruck W; Gleich G; Ransohoff RM; Trebst C; Weinshenker B; Wingerchuk D; Parisi JE; Lassmann H
Brain; 2002 Jul; 125(Pt 7):1450-61. PubMed ID: 12076996
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis.
Lucchinetti CF; Brück W; Rodriguez M; Lassmann H
Brain Pathol; 1996 Jul; 6(3):259-74. PubMed ID: 8864283
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
Henderson AP; Barnett MH; Parratt JD; Prineas JW
Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
[TBL] [Abstract][Full Text] [Related]
9. Patterns of oligodendroglia pathology in multiple sclerosis.
Ozawa K; Suchanek G; Breitschopf H; Brück W; Budka H; Jellinger K; Lassmann H
Brain; 1994 Dec; 117 ( Pt 6)():1311-22. PubMed ID: 7820568
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrocytes in the early course of multiple sclerosis.
Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: lessons from neuropathology.
Lucchinetti CF; Brueck W; Rodriguez M; Lassmann H
Semin Neurol; 1998; 18(3):337-49. PubMed ID: 9817538
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
Lassmann H
Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
[TBL] [Abstract][Full Text] [Related]
13. Are current immunological concepts of multiple sclerosis reflected by the immunopathology of its lesions?
Lassmann H; Vass K
Springer Semin Immunopathol; 1995; 17(1):77-87. PubMed ID: 7482228
[TBL] [Abstract][Full Text] [Related]
14. Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis.
Lassmann H; Suchanek G; Ozawa K
Ann Neurol; 1994; 36 Suppl():S42-6. PubMed ID: 8017888
[TBL] [Abstract][Full Text] [Related]
15. Altered human oligodendrocyte heterogeneity in multiple sclerosis.
Jäkel S; Agirre E; Mendanha Falcão A; van Bruggen D; Lee KW; Knuesel I; Malhotra D; Ffrench-Constant C; Williams A; Castelo-Branco G
Nature; 2019 Feb; 566(7745):543-547. PubMed ID: 30747918
[TBL] [Abstract][Full Text] [Related]
16. Experimental patterns related to multiple sclerosis pathology.
Macchi G
Riv Neurol; 1987; 57(3):145-53. PubMed ID: 3313666
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
[TBL] [Abstract][Full Text] [Related]
18. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
19. Oligodendrocytes and the early multiple sclerosis lesion.
Prineas JW; Parratt JD
Ann Neurol; 2012 Jul; 72(1):18-31. PubMed ID: 22829266
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination.
Lee NJ; Ha SK; Sati P; Absinta M; Luciano NJ; Lefeuvre JA; Schindler MK; Leibovitch EC; Ryu JK; Petersen MA; Silva AC; Jacobson S; Akassoglou K; Reich DS
Brain; 2018 Jun; 141(6):1637-1649. PubMed ID: 29688408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
